Accelerated tumor growth in mice deficient in DNAM-1 receptor

Journal of Experimental Medicine

Volumn 205, Issue 13, 2008, Pages 2959-2964

  Iguchi Manaka, Akiko ^a   Kai, Hirayasu ^a   Yamashita, Yumi ^a   Shibata, Kai ^a   Tahara Hanaoka, Satoko ^a   Honda, Shin Ichiro ^a   Yasui, Teruhito ^b   Kikutani, Hitoshi ^b   Shibuya, Kazuko ^a   Shibuya, Akira ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; DIMETHYLBENZ[A]ANTHRACENE; PROTEIN DNAM 1; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN; CD226 ANTIGEN; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MORTALITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FIBROSARCOMA; IMMUNOSURVEILLANCE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; TUMOR CELL DESTRUCTION; TUMOR GROWTH; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CYTOLOGY; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MOUSE MUTANT; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CARCINOGENS; CELL LINE, TUMOR; FIBROSARCOMA; HUMANS; KILLER CELLS, NATURAL; MALE; METHYLCHOLANTHRENE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; NEOPLASMS; PAPILLOMA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 59649091694     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20081611     Document Type: Article

References (31)

1. Dunn, G.P., L.J. Old, and R.D. Schreiber. 2004. The three Es of cancer immunoediting. Annu. Rev. Immunol. 22:329-360.
2. Swann, J.B., and M.J. Smyth. 2007. Immune surveillance of tumors. J. Clin. Invest. 117:1137-1146.
3. Lanier, L.L. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225-274.
4. Dunn, G.P., C.M. Koebel, and R.D. Schreiber. 2006. Interferons, immunity and cancer immunoediting. Nat. Rev. Immunol. 6:836-848.
5. Shibuya, A., D. Campbell, C. Hannum, H. Yssel, K. Franz-Bacon, T. McClanahan, T. Kitamura, J . Nicholl, G.R. Sutherland, L.L. Lanier, and J.H. Phillips. 1996. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity. 4:573-581.
6. Kojima, H., H. Kanada, S. Shimizu, E. Kasama, K. Shibuya, H. Nakauchi, T. Nagasawa, and A. Shibuya. 2003. CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells. J. Biol. Chem. 278:36748-36753.
7. Shibuya, A., S. Tahara-Hanaoka, and K. Shibuya. 2005. DNAM-1 (CD226): a two-sword fencer for innate and adaptive immunity. Current Medical Chemistry - Anti-Inflammatory and Anti-Allergy Agents. 4:53-58.
8. Shibuya, K., L.L. Lanier, J .H. Phillips, H.D. Ochs, K. Shimizu, E. Nakayama, H. Nakauchi, and A. Shibuya. 1999. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity. 11:615-623.
9. Shibuya, K., J. Shirakawa, T. Kameyama, S. Honda, S. Tahara-Hanaoka, A. Miyamoto, M. Onodera, T. Sumida, H. Nakauchi, H. Miyoshi, and A. Shibuya. 2003. CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J. Exp. Med. 198:1829-1839.
10. Bottino, C., R. Castriconi, D. Pende, P. Rivera, M. Nanni, B. Carnemolla, C. Cantoni, J. Grassi, S. Marcenaro, N. Reymond, et al. 2003. Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 198:557-567.
11. Tahara-Hanaoka, S., K. Shibuya, Y. Onoda, H. Zhang, S. Yamazaki, A. Miyamoto, S. Honda, L.L. Lanier, and A. Shibuya. 2004. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int. Immunol. 16:533-538.
12. Tahara-Hanaoka, S., A. Miyamoto, A. Hara, S. Honda, K. Shibuya, and A. Shibuya. 2005. I dentification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands. Biochem. Biophys. Res. Commun. 329:996-1000.
13. Lopez, M., M. Aoubala, F. J ordier, D. I snardon, S. Gomez, and P. Dubreuil. 1998. The human poliovirus receptor related 2 protein is a new hematopoietic/endothelial homophilic adhesion molecule. Blood. 92:4602-4611.
14. Iwasaki, A., R. Welker, S. Mueller, M. Linehan, A. Nomoto, and E. Wimmer. 2002. Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection. J. Infect. Dis. 186:585-592.
15. Masson, D., A. Jarry, B. Baury, P. Blanchardie, C. Laboisse, P. Lustenberger, and M.G. Denis. 2001. Overexpression of the CD155 gene in human colorectal carcinoma. Gut. 49:236 240.
16. Tahara-Hanaoka, S., K. Shibuya, H. Kai, A. Miyamoto, Y. Morikawa, N. Ohkochi, S. Honda, and A. Shibuya. 2006. Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor. Blood. 107:1491-1496.
17. Carlsten, M., N.K. Bjorkstrom, H. Norell, Y. Bryceson, T. van Hall, B.C. Baumann, M. Hanson, K. Schedvins, R. Kiessling, H.G. Ljunggren, and K.J. Malmberg. 2007. DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells. Cancer Res. 67:1317-1325.
18. Castriconi, R., A. Dondero, M.V. Corrias, E. Lanino, D. Pende, L. Moretta, C. Bottino, and A. Moretta. 2004. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction. Cancer Res. 64:9180-9184.
19. Pende, D., G.M. Spaggiari, S. Marcenaro, S. Martini, P. Rivera, A. Capobianco, M. Falco, E. Lanino, I. Pierri, R. Zambello, et al. 2005. Analysis of the receptor-ligand interactions in the natural killer- mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the poliovirus receptor (CD155) and nectin-2 (CD112). Blood. 105:2066-2073.
20. El-Sherbiny, Y.M., J .L. Meade, T.D. Holmes, D. McGonagle, S.L. Mackie, A.W. Morgan, G. Cook, S. Feyler, S.J. Richards, F.E. Davies, et al . 2007. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res. 67:8444-8449.
21. Guerra, N., Y.X. Tan, N.T. Joncker, A. Choy, F. Gallardo, N. Xiong, S. Knoblaugh, D. Cado, N.M. Greenberg, and D.H. Raulet. 2008. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity. 28:571-580.
22. Khong, H.T., and N.P. Restifo. 2002. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat. Immunol. 3:999-1005.
23. Girardi, M., D.E. Oppenheim, C.R. Steele, J.M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R.E. Tigelaar, and A.C. Hayday. 2001. Regulation of cutaneous malignancy by gammadelta T cells. Science. 294:605-609.
24. Gao, Y., W. Yang, M. Pan, E. Scully, M. Girardi, L.H. Augenlicht, J. Craft, and Z. Yin. 2003. γδ T cells provide an early source of interferon γ in tumor immunity. J. Exp. Med. 198:433-442.
25. Smyth, M.J., K.Y. Thia, S.E. Street, E. Cretney, J.A. Trapani, M. Taniguchi, T. Kawano, S.B. Pelikan, N.Y. Crowe, and D.I. Godfrey. 2000. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191:661-668.
26. Smyth, M.J., N.Y. Crowe, and D.I. Godfrey. 2001. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int. Immunol. 13:459-463.
27. Crowe, N.Y., J.M. Coquet, S.P. Berzins, K. Kyparissoudis, R. Keating, D.G. Pellicci, Y. Hayakawa, D.I. Godfrey, and M.J. Smyth. 2005. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202:1279-1288.
28. Cretney, E., K. Takeda, H. Yagita, M. Glaccum, J.J. Peschon, and M.J. Smyth. 2002. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J. Immunol. 168:1356-1361.
29. Takeda, K., M.J. Smyth, E. Cretney, Y. Hayakawa, N. Kayagaki, H. Yagita, and K. Okumura. 2002. Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J. Exp. Med. 195:161-169.
30. Yang, Y., and B. Seed. 2003. Site-specific gene targeting in mouse embryonic stem cells with intact bacterial artificial chromosomes. Nat. Biotechnol. 21:447-451.
31. Gorer, P.A. 1950. Studies in antibody response of mice to tumor inoculation. Br. J. Cancer. 4:372-379.